Clinical Trial Update: Pain Biomarker Study [Phase 1]

View source ↗

Summary

Phase 1 pain biomarker trial is currently enrolling by invitation. The study targets migraine and several trigeminal autonomic cephalgias, including cluster hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cluster Headache
• Hemicrania Continua
• Migraine
• Paroxysmal Hemicrania
• Short-lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing
• Trigeminal Autonomic Cephalgia

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Migraine, Cluster Headache | Phase 1 | Status: ENROLLING_BY_INVITATION